GORMAN KEVIN CHARLES bought NBIX
February 8, 2025 · Form 4 insider transaction
GORMAN KEVIN CHARLES bought 4,318 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,318
Price
$0.00
Total value
N/A
InsiderGORMAN KEVIN CHARLES
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 8, 2025
Filing dateFebruary 12, 2025
Shares owned after521,348
OwnershipDirect
10b5-1 planNo
AmendedNo